Concepedia

Vincenzo Famiglietti

VF

25

Publications

791

Citations

15

H-Index

2018

Active since

Affiliations

University of Campania "Luigi Vanvitelli"(Current)

Casa Sollievo della Sofferenza

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Istituti di Ricovero e Cura a Carattere Scientifico

Fondazione IRCCS Istituto Nazionale dei Tumori

Vincenzo Famiglietti is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, oncology, and colorectal cancer.

ORCID

Top concepts

Publications per year

2018–2024

25

Publications

25

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 174 citations · Full text

Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience

Pietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta et al. · Cancers · 2019 · 65 citations · Full text

, , +24

Gut microbiota correlates with antitumor activity in patients with <scp>mCRC</scp> and <scp>NSCLC</scp> treated with cetuximab plus avelumab

Giulia Martini, Davide Ciardiello, Marcello Dallio et al. · International Journal of Cancer · 2022 · 61 citations · Full text

, , +17

Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory <i>RAS</i> Wild-Type Metastatic Colorectal Cancer

Stefania Napolitano, Vincenzo De Falco, Giulia Martini et al. · JAMA Oncology · 2023 · 53 citations · Full text

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello et al. · ESMO Open · 2020 · 46 citations · Full text

Rows per page

1–5 of 25